Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11 Suppl
pubmed:dateCreated
2011-9-13
pubmed:abstractText
Although human embryonic stem cells (hESC) have enormous potential for cell replacement therapy of heart failure, immune rejection of hESC derivatives inevitably would occur after transplantation. We therefore aimed to generate a hypoantigeneic hESC line with improved survival characteristics.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1524-4539
pubmed:author
pubmed:issnType
Electronic
pubmed:day
13
pubmed:volume
124
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S3-9
pubmed:meshHeading
pubmed-meshheading:21911816-Animals, pubmed-meshheading:21911816-Cell Survival, pubmed-meshheading:21911816-Cells, Cultured, pubmed-meshheading:21911816-Embryonic Stem Cells, pubmed-meshheading:21911816-Gene Knockdown Techniques, pubmed-meshheading:21911816-Graft Survival, pubmed-meshheading:21911816-HLA Antigens, pubmed-meshheading:21911816-Humans, pubmed-meshheading:21911816-Immune Tolerance, pubmed-meshheading:21911816-Immunosuppression, pubmed-meshheading:21911816-Male, pubmed-meshheading:21911816-Mice, pubmed-meshheading:21911816-Mice, Inbred BALB C, pubmed-meshheading:21911816-Mice, Knockout, pubmed-meshheading:21911816-Mice, Nude, pubmed-meshheading:21911816-Mice, SCID, pubmed-meshheading:21911816-Models, Animal, pubmed-meshheading:21911816-Stem Cell Transplantation, pubmed-meshheading:21911816-T-Lymphocytes, pubmed-meshheading:21911816-Time Factors, pubmed-meshheading:21911816-Transplantation, Heterologous
pubmed:year
2011
pubmed:articleTitle
Human leukocyte antigen I knockdown human embryonic stem cells induce host ignorance and achieve prolonged xenogeneic survival.
pubmed:affiliation
Department of Cardiovascular Surgery, Stanford University, Stanford, CA, USA. t.deuse@uke.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't